The Landscape of Cancer Research 2022
Returning for a second year, this online event will provide researchers with a unique opportunity to hear about the advances taking place within cancer research. We will bring together a broad cross-section of experts to share their work in areas such as omics, immunology, drug discovery and cell science.
SARS-CoV-2–Specific B Cell Detection and Therapeutic Antibody Discovery
To combat the COVID-19 pandemic, comprehensive characterization of humoral and cellular immune responses to SARS-CoV-2 is essential.
Genomic Tools for Psilocybe cubensis Propagation
Kevin McKernan, CSO at Medicinal Genomics will be joining us to discuss genetic variation in the Psilocybe cubensis synthesis pathway and the design of qPCR assays for simultaneous quantification of E. coli and Salmonella species contamination concurrent with Psilocybe cubensis species identification.
Innovations in Disease Modeling 2022
This inaugural online symposium will explore the tools and techniques being used to study diseases in the lab. Focus will be given to cell culture, organ-on-a-chip and organoid models, as well as, how innovations are enabling researchers to elucidate the underlying biological mechanisms of disease and support diagnostic and therapeutic development.
Comprehensive Analysis of Next-Generation Biologics
New methods, techniques and efficient data analysis software in liquid chromatography-tandem mass spectrometry (LC-MS/MS) hold the key for accelerating the development of NGBs and increasing their availability.
Zooming in on SARS-CoV-2 Replication to Develop Antiviral Therapies
Antiviral drugs that slow SARS-CoV-2 replication in patient cells are critical for curbing the pandemic. For RNA viruses such as SARS-CoV-2, genome duplication hinges on RNA polymerase, making the enzyme an ideal therapeutic target for drug development.